Trial Profile
Clinical Trials Insight: 700012855
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2006
Price :
$35
*
At a glance
- Drugs HRC 302 (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 30 Mar 2006 New trial record.